Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 4, 2021

View Archived Issues

Discovery of novel potent and selective IRAK1 degraders

Medshine Discovery patents new BCL2/BCL2L1 inhibitors

Suzhou Zanrong Pharma discloses HER2 inhibitors

Marvel Biotechnology identified new adenosine A2A receptor antagonists

Jinan University describes new tyrosine protein kinase inhibitors for cancer

French researchers patent BTNL8-binding antibodies for IBD

IL-4 and IL-13 drive atopic dermatitis pathology by regulating sex steroid hormone synthesis

A receptor-ligand discovery platform for unbiased interactome discovery of membrane proteins

Preclinical evaluation of novel IDO1 apoenzyme inhibitors

GlaxoSmithKline details discovery of new class of BET BD2 inhibitors

KATNAL2 gene mutations tied to male infertility

miR-7 recovers motor function after spinal cord injury

Model illuminates roles of mononuclear phagocyte subsets in renal disease

Nobel Prize for Red Hot Chili Pepper and Cool Mint receptors